Records containing: Refractory Pancreatic Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I Clinical Trial of M6620 (VX-970, Berzosertib) in Combination With the Topoisomerase I Inhibitor Irinotecan in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-05-06Phase II Clinical Trial Evaluating Intravenous AZD9150 (Antisense STAT3) With MEDI4736 (Anti-PD-L1) in Patients With Advanced Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2023-11-18A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-03-10Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid Cancers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-09-28Phase I Study of GSK525762C and Entinostat in Advanced and Refractory Solid Tumors and Lymphomas